NCT06859775 2025-06-06
SHR-A1811 Combination Regimen for the Treatment of Recurrent or Metastatic Cervical Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1/2 Recruiting
Clinical Trials
9 trialsNCT01088347 2024-04-19
Mapatumumab, Cisplatin and Radiotherapy for Advanced Cervical Cancer
University Medical Center Groningen
Phase 1/2 Completed
NCT06241235 2024-04-02
Study of ZG005 in Combination With Paclitaxel＋Platinum-based ± Bevacizumab in Patients With Advanced Cervical Carcinoma
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 1/2 Recruiting
NCT01076400 2023-09-18
MK-1775-008
Merck Sharp & Dohme LLC
Phase 1/2 Terminated
NCT01230996 2019-04-24
DEPICT
Barts & The London NHS Trust
Phase 1/2 Completed
NCT02095119 2015-04-14
A Monoclonal Antibody, Nimotuzumab, as Treatment for Recurrent or Metastatic Cervical Cancer
National Institute of Cancerología
Phase 1/2 Completed
NCT00012012 2015-01-07
Radiation Therapy and Cisplatin With or Without Amifostine for Patients With Stage IIIB or IVA Cervical Cancer
Radiation Therapy Oncology Group
Phase 1/2 Completed
NCT00023660 2013-11-19
Radiation Therapy Plus Celecoxib, Fluorouracil, and Cisplatin in Patients With Locally Advanced Cervical Cancer
Radiation Therapy Oncology Group
Phase 1/2 Completed
NCT00003379 2013-05-27
Radiation Therapy Plus Paclitaxel and Cisplatin in Treating Patients With Cervical Cancer
GOG Foundation
Phase 1/2 Completed